IntelGenx Technologies (IGXT) has released an update.
IntelGenx Technologies Corp. has revised its loan agreement with atai Life Sciences, securing an additional $2 million in funding, with the option for atai to convert the loan into company stock. This move, aimed at bolstering IntelGenx’s financial standing, comes with the issuance of warrants allowing atai to purchase shares at a set price, further entwining the financial interests of both companies.
For further insights into IGXT stock, check out TipRanks’ Stock Analysis page.
